Scilla Health Management App
Co-Principal Investigators: Mark W. Newman, Ph.D. and Mark Ackerman, Ph.D.
Ph.D and Graduate Student: Bomi Shim; Pei-Yao Hung
The Spinal Cord Injury Living and Learning System leverages state-of-the-art mobile and web-based technology to provide tailorable, context-aware and adaptive, self-management and patient education capabilities in ways that are effective, appropriate, and cost-effective. By leveraging commodity platforms, we ensure that the resulting system will have the potential for commercial development, marketing, and distribution.
Through this project, we will design, build and evaluate SCILLS (“Skills,” the Spinal Cord Injury Living and Learning System), a cloud-based mobile system for helping persons with spinal cord injuries or disease (SCI/D) acquire self-management skills through a clinician-managed virtual coaching program.
The system will be designed, developed, and evaluated through extensive interactions and repeated testing with both patients and clinicians, ensuring that SCILLS will be developed and tested in an appropriate environment and that it will be useful for and usable by members of the target communities.
Interested in participating in this paid study to evaluate Scilla? Download this flyer for more information or read below:
Help us evaluate Scilla!
If you are selected to participate in our evaluation study, you can
1. Install Scilla on your Android or iOS device
2. Use Scilla for up to 8 weeks
3. Provide feedback through interviews and questionnaires 4. Earn up to $140*!
* Specific compensation depends on duration and degree of participation
Who can participate?
To be eligible for this study, you need to
• be starting to take Baclofen or adjusting your Baclofen dosage
• have an Internet-connected iOS or Android device (phone or tablet)
• provide an email address that you check regularly
• be either the person who is planning to take Baclofen or their primary caregiver
• speak English fluently and be at least 18 years of age
How do I join?
If you are determined to be eligible based on a medical record review, the study team will contact you to invite you to enroll. If you have questions about the study at any time you can contact the study team at firstname.lastname@example.org.
This study has been approved by the University of Michigan Human Subjects Institutional Review Board (HUM00163526).